SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-17-002343
Filing Date
2017-09-26
Accepted
2017-09-26 17:22:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 6 TO THE SCHEDULE 13D sc13da606922004_09262017.htm SC 13D/A 72419
2 SECURITIES PURCHASE AGREEMENT ex991to13da606922004_092617.htm EX-99.1 408733
  Complete submission text file 0000921895-17-002343.txt   482494
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D/A

Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Subject) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89516 | Film No.: 171102777
SIC: 3841 Surgical & Medical Instruments & Apparatus